Clinical Lab Group Gets Go-Ahead On Medicare Payment Suit
Executive Summary
The American Clinical Laboratory Association (ACLA) may proceed with a lawsuit against the US Department of Health and Human Services, an appeals court has ruled. The suit alleges that the agency is setting lab test payment rates unfairly.
You may also be interested in...
In Vitro Diagnostic Industry’s Political Playbook Rewritten As Firms Lobby On COVID-19 Legislation
Test kit and lab firms spent tens of thousands of dollars in the first quarter of 2020 lobbying legislators to win provisions in coronavirus protection laws to ensure COVID-19 diagnostics would be a top US legislative priority.
LAB Act Included In Must-Pass, US 2020 Appropriations Bill Legislation Due To Be Signed By 20 December
The US Congress and President Donald Trump are expected to clear and sign off on the Laboratory Access for Beneficiaries Act favored by the clinical laboratory industry and manufacturers of in vitro test kits, as part of a must-pass appropriations bill intended to keep the US government open and funded for the balance of the 2020 fiscal year.
Medicare Planning To Pay Too Much For Lab Services? Grassley And GAO Say 'Yes'
Senate Finance Committee Chairman Chuck Grassley says Medicare would be overpaying for laboratory tests if it goes forward with its planned increases to diagnostic prices on the Medicare Clinical Lab Fee Schedule (CLFS). Industry groups disagree.